MICALOVE RAPHAEL: Open Payments
NPI 1386415867 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$579 in 22 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $526 · 2025 $579
Food & beverage: $541Education: $38
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $185 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $96 |
| Exact Sciences Corporation | 3 | $86 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| Amgen Inc. | 2 | $41 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $28 |
| Hologic Sales and Service, LLC | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $17 |
Products named: Ozempic, JARDIANCE, Cologuard Collection Kit, AIRSUPRA, OTEZLA, TRELEGY ELLIPTA, Kerendia, Wegovy.
Industry payments across PA — which companies pay providers there.
